Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab
- PMID: 29329696
- DOI: 10.1016/j.ejca.2017.12.004
Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab
Comment in
-
Response to Letter to the Editor, 'Pharmacokinetics partly explains the relationship between CEA level and survival of colorectal cancer patients treated with ramucirumab,' by Ibrahim et al.Eur J Cancer. 2018 Mar;92:121-122. doi: 10.1016/j.ejca.2018.01.070. Epub 2018 Feb 9. Eur J Cancer. 2018. PMID: 29433790 No abstract available.
Comment on
-
Baseline carcinoembryonic antigen as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma phase III trial.Eur J Cancer. 2017 Jun;78:61-69. doi: 10.1016/j.ejca.2017.03.007. Epub 2017 Apr 13. Eur J Cancer. 2017. PMID: 28412590 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

